See also this year's filing and all EDGAR filings for this company.
PDF Report 0001590750_2026_Viridian_Therapeutics_Inc_DE.pdf
Logs
Graph
Absolute values for 0001590750, Viridian Therapeutics Inc DE
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 3,957,000 |
| 2 | AssetsCurrent | 894,233,000 |
| 3 | PropertyPlantAndEquipment | 1,228,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 2,341,000 |
| 6 | LiabilitiesCurrent | 70,696,000 |
| 7 | remainder_Liabilities | 104,214,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 95,315,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 338,929,000 |
| 17 | remainder_Revenues | 70,849,000 |
| 18 | remainder_NetIncome | 20,794,000 |
| 19 | remainder_ComprehensiveNetIncome | 457,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 899,418,000 |
| 1 | Liabilities | 177,251,000 |
| 2 | Expenses | 434,244,000 |
| 3 | Revenues | 70,849,000 |
| 4 | StockholdersEquity | 722,167,000 |
| 5 | NetIncome | -342,601,000 |
| 6 | ComprehensiveNetIncome | -342,144,000 |
| 7 | BaseVar | 801,506,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.31 |
| 9 | EconomicCapitalRatio | 1.92 |
Edgar->Model Mapping
Feature Distribution
Change over Time
